Anaphylactic shock because of sublingual immunotherapy overdose during third year of maintenance dose.
Blazowski
L
L
blazowsk@ks.onet.pl
D000286:Administration, Sublingual; D000293:Adolescent; D000707:Anaphylaxis / Q000139:chemically induced* / Q000503:physiopathology / Q000628:therapy; D001249:Asthma / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D062787:Drug Overdose / Q000150:complications; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D007167:Immunotherapy; D008134:Long-Term Care; D012221:Rhinitis, Allergic, Perennial / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D018570:Risk Assessment; D013997:Time Factors
D007166:Immunosuppressive Agents